GTC
CGON icon

Ghost Tree Capital’s CG Oncology CGON Stock Holding History

Ghost Tree Capital’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$9.43M Sell
250,000
-10,000
-4% -$351K 2.85% 9
2024
Q2 		$8.21M Buy
260,000
+185,000
+247% +$6.41M 2.57% 14
2024
Q1 		$3.29M Buy
+75,000
New +$3.06M 0.91% 37

Other funds holding CGON

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ghost Tree Capital's CGON Position: Q3 2024 in Review

Ghost Tree Capital reduced its CG Oncology (CGON) stake by 3.8% in Q3 2024, selling an estimated $351K and leaving 250,000 shares worth $9.43M. The position accounts for 2.85% of the portfolio, ranked #9.

Ghost Tree Capital first reported a position in CGON in Q1 2024 and has held it in 3 quarters since. 121 funds tracked by Wall St. Rank hold CGON as of Q3 2024.

  • Ghost Tree Capital held 250,000 shares of CG Oncology worth $9.43M as of Q3 2024.
  • Ghost Tree Capital sold 10,000 CG Oncology shares in Q3 2024, an estimated $351K.
  • CG Oncology made up 2.85% of Ghost Tree Capital's portfolio in Q3 2024, its #9 holding.
  • Ghost Tree Capital first reported a position in CG Oncology in Q1 2024 and has held it in 3 quarters since.
  • 121 funds tracked by Wall St. Rank held CG Oncology as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.